Skip to main content
Equibles

Creative Planning

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1540235 OVERLAND PARK, KS
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,382,250
+$715,350 QoQ
Shares Held
285,000
0.0% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 114 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creative Planning holds $457,365,908 across 219 Biotechnology names. ZNTL ranks #68 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 127,672 $63,418,511
2 REGN
Regeneron Pharmaceuticals, Inc.
 36,949 $23,039,178
3 EXEL
Exelixis, Inc.
 270,292 $14,706,586
4 INCY
Incyte Corp
 110,664 $12,544,870
5 CYTK
Cytokinetics Inc
 141,939 $12,091,783
6 RVMD
Revolution Medicines, Inc.
 64,120 $12,008,393
7 ARGX
Argenx SE
 12,744 $11,823,500
8 BMRN
Biomarin Pharmaceutical Inc
 153,161 $8,763,872

All Filings in ZNTL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,382,250 285,000
2026-03-31 $666,900 285,000
2025-12-31 $351,000 260,000
2025-09-30 $392,600 260,000
2025-06-30 $35,194 30,340
2025-03-31 $376,071 236,523
2024-12-31 $121,512 40,103
2024-09-30 $41,584 11,300
2024-06-30 $54,801 13,399
2024-03-31 $182,658 11,590
2023-12-31 $166,650 11,000